Dr. Albert Y. Wu earned his B.S. in Molecular Biophysics and Biochemistry from Yale University and his M.D. and Ph.D. in Molecular and Cellular Biology from the University of Washington. He completed ophthalmology residency training at the Moran Eye Center at the University of Utah, followed by a two-year ASOPRS fellowship in Ophthalmic Plastic and Reconstructive Surgery at the University of Toronto. He subsequently served on the faculty at Mount Sinai and the New York Eye and Ear Infirmary from 2011 to 2017.
Since 2017, Dr. Wu has been on the faculty of the Department of Ophthalmology at Stanford University and is now with the University of Ottawa. His research, supported by the National Eye Institute, centers on developing stem cell–based therapies to restore vision and regenerate the ocular surface. As principal investigator of the Ophthalmic Stem Cell and Regenerative Medicine Laboratory, he has led major initiatives such as the Human Eye Cell Atlas and translational efforts in corneal tissue engineering and ocular surface reconstruction.
Dr. Wu has published widely in journals including JAMA Ophthalmology, Ophthalmic Plastic & Reconstructive Surgery, Clinical and Experimental Ophthalmology, and Retina, and serves as a reviewer for American Journal of Ophthalmology, OPRS, and Human Gene Therapy.